Nvidia's business model focuses on manufacturing advanced GPUs and data center products, with significant revenue growth.

Regenxbio Inc (RGNX) showcases robust financial positioning and strategic progress in gene therapy, despite challenges in ...

ASML-imec deal; Intel Foundry's future; European tech consortium; photonics-related acquisitions; global chip market up; new security IP and algorithms; neuromorphic AI chip; adaptive MCUs; auto ...

Brookline Capital Management issued their FY2024 EPS estimates for Perspective Therapeutics in a report released on Monday, ...

Stock analysts at Noble Financial issued their FY2024 earnings per share (EPS) estimates for Gyre Therapeutics in a research report issued to clients and investors on Tuesday, March 11th. Noble ...

Nvidia leads in AI data center revenue, tripling its competitors' combined earnings in Q4 2024. AMD's data center revenue grew 94% in 2024, driven by Instinct GPUs and EPYC CPUs. Intel and IBM face ...

But we digress. The gap in market share between TSMC and Samsung Foundry increased sequentially from 55.6% in Q3 to 59% in Q4 ...

We recently published a list of Top 10 Semiconductor Stocks to Buy Now. In this article, we are going to take a look at where ...

AMD CEO Lisa Su is confident in the company's AI dominance, fueled by growth in AI GPUs, server CPUs, and strategic ...

Advanced Micro Devices (AMD) has had a rough year. The stock has taken a 55% beating since peaking last year, weighed down by ...

In some AI inference applications, the MI325X GPUs designed by AMD may outperform the H200 offered by Nvidia. Read why AMD ...

Advanced Micro Devices (NASDAQ:AMD) stock has been on a rough ride, plunging 53% over the past 12 months and dropping below ...